Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DXCM
DXCM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DXCM News
Omnipod 5 Insulin Delivery System Launches in Spain
2d ago
Yahoo Finance
Investigation into DexCom Shareholder Rights
4d ago
PRnewswire
Two Stocks Wall Street Loves and One to Sell
6d ago
Yahoo Finance
Deutsche Bank Initiates Buy Ratings for Insulet and DexCom Amid Market Recovery
Jun 23 2026
seekingalpha
Dexcom Launches Pediatric Stelo and New App Experience
Jun 23 2026
Newsfilter
Major Rating Changes on Wall Street
Jun 23 2026
CNBC
Abbott's Q2 Earnings Preview and Growth Drivers
Jun 20 2026
Fool
Abbott's Diversified Business Fuels Growth
Jun 20 2026
NASDAQ.COM
FDA Approves DexCom's OTC Glucose Monitor for Children
Jun 12 2026
seekingalpha
Dexcom CONNECT Trial Significantly Improves Glucose Control in Type 2 Diabetes Patients
Jun 06 2026
Newsfilter
Dexcom CONNECT Trial Significantly Improves Glucose Control in Type 2 Diabetes Patients
Jun 06 2026
Yahoo Finance
Competitive Analysis of Diabetes Monitoring Market
Jun 04 2026
NASDAQ.COM
Comparative Analysis of Diabetes Management Innovations
Jun 04 2026
Fool
Dexcom Unveils Key Findings at ADA Conference
Jun 04 2026
Newsfilter
Investment Opportunities in Meta and Dexcom Amid Market Volatility
Jun 02 2026
Fool
Dexcom Establishes Permanent Council to Drive Innovation
Jun 02 2026
Newsfilter
Show More News
